| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.0M | +9.3% |
| R&D Expense | $2.4M | +2.6% |
| SG&A Expense | $2.4M | -14.4% |
| Operating Income | -$55K | +96.5% |
| Pre-tax Income | -$3.2M | +32.5% |
| Income Tax | $6K | +120.2% |
| Net Income | -$3.2M | +31.9% |
| EPS (Basic) | -$0.01 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | +103.7% |
| Accounts Receivable | $1.0M | +2.7% |
| Inventory | $403K | -3.7% |
| Current Assets | $3.2M | +20.6% |
| Total Assets | $4.6M | +28.1% |
| Current Liabilities | $46.7M | +6.6% |
| Total Liabilities | $47.7M | +8.2% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $805K | +437.4% |
| Capital Expenditures | $9K | -81.2% |
| Investing Cash Flow | -$18K | +87.4% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | $797K | +379.7% |
| -$43.0M |
| -6.4% |